T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 6,793,788 shares of CABA stock, worth $9.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,793,788
Previous 3,970,026
71.13%
Holding current value
$9.04 Million
Previous $5.5 Million
87.8%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CABA
# of Institutions
93Shares Held
77MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$12.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$11.7 Million0.02% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$6.65 Million0.77% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.8MShares$6.38 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...